Search Within
Document Type
305-53-3
Applied Filters:
Keyword:'305-53-3'
Showing 1-30 of 60 results for "305-53-3" within Technical Documents
Data Sheet - SAB4200862
I. and Hensel M., Microbes Infect.,
3: 549–59 (2001).
8. Broz P., et al., Gut Microbes, 3: 62–70 (2012).
9. Haraga A., et al., Nat Rev Microbiol., 6:
53–66 (2008).
10. Lopez FE.
Product Information Sheet - P5629
engineering for protein purification:
recovery of beta-galactosidase fused proteins.
Bioseparation, 1(3-4), 305-310 (1990).
6. Pardue, K., and Williams, D., Quantitative
determination of non-ionic surfactants
Data Sheet - H4042
al., Endocrine Rev., 17, 385-410
(1996).
3. Le Roith, D. et al., Endocrine Rev., 22, 53-74
(2001).
4. Roskam, W. et al., Nucleic Acids Res., 7, 305-320
(1979).
5. Welniak, L.A. et al., J. Leukoc
Data Sheet - P2980
al., Nature, 17,182-184 (1986).
6. Yajima, M. et al., J. Biochem., 83, 305 (1978).
7. Befus A. et al., J. Immunol., 1999 163, 47-53
(1999).
8. Di Pierro, F. et al., J. Pharmacol. Toxicol. Methods
Product Information Sheet - G1660
of neuronal
nicotinic but not of muscarinic acetylcholine
receptors. J. Pharmacol. Exp. Ther., 305(3),
1024-1036 (2003).
6. Hellstrom-Lindahl, E., et al., Increased levels of
tau protein in SH-
Data Sheet - P7208
al., Nature, 17,182-184 (1986).
6. Yajima, M. et al., J. Biochem., 83, 305 (1978).
7. Befus A. et al., J. Immunol., 1999 163, 47-53
(1999).
8. Di Pierro, F. et al., J. Pharmacol.
Product Information Sheet - S4776
al., Endocrine Rev., 17, (385-410
(1996).
2. Le Roith, D., et al., Endocrine Rev., 22, (53-74)
(2001).
3. Welniak, L.A., et al., J. Leukoc. Biol., 71, (381-
387) 2002.
4. Chen, H.C., et al.
Data Sheet - SAB4200740
Cleveland DW., J Cell Biol.,
108, 579-93 (1989).
10. Black MM., and Lee V., J Neurosci, 8, 3296-305
(1988).
11. Yuan A., et al., J Cell Sci, 125, 3257-63 (2012).
12. Abe A., et al., J.
Quality Control Range Sheet- B6062-103 and B6062-203
pg/mL
sCD137 Control 1 84 – 174 pg/mL GCP-2 Control 1 30 – 62 pg/mL
Control 2 305 – 633 pg/mL Control 2
XP725 Antibody Number-Lot Number 071M4826
e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32
Product Information Sheet - CS0780
Mol. Genet., 11,
1343-1350 (2002).
3. Olah, A.V., et al., Age dependence of serum
β-N-acetylhexosaminidase (NAG) activity. Clin.
Chem. Lab. Med., 42, 305-306 (2004).
4. Gil-Martin, E., et al
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
163 4 142 5 166 3 103 3 141 3 223 5
IPI00736860 Hypothetical protein LOC 246 4 373 4 287 4 468 4 305 4 389 4
IPI00027737 Melanoma-derived leucine zipper-containing
extranuclear factor
50 1 50
Data Sheet - 74188
. Hokke, et al., Glycoconjugate J., 1996, 13, 687.
62 K. Sujino, et al., Carbohydr. Res., 1998, 305, 483.
63 C.L.M. Stults, et al., Glycobiology., 1999, 9, 661.
64 X. Qian, et al., J. Am. Chem.
59505 Galactosyltransferase Kit
O-fucosylated and sialylated modifications served as
acceptors53 as well as 3-O-methyl-GlcNAc,38,54 3-deoxy-GlcNAc, 3-O-allyl-GlcNAcOBu and 3-oxo-
GlcNAc.55 Several modifications of GlcNAc that were
An Update on Ligands for Prostanoid Receptors
al., Prostaglandins, 53, 83-90 (1997).
70. Whittle, B.J., et al., Prostaglandins, 19, 605-627 (1980).
71. Skuballa, W., Vorbruggen, H., Adv. Prost. Thromb. Leukot. Res., 11, 229-305 (1983).
72. Sturzebecher
Specific Detection of Full-length Glucagon from Blood Samples Using a Chemiluminescent ELISA Kit
Sample # EMD Millipore Competitor B
1 7.5 3,629
2 46.4 3,460
3 22.0
4 25.1 383
5 21.0
6 36.5 305
7 13.0
8 22.5
Sample # EMD
Product Information Sheet - CS0490
family. Cell Signal., 15, 463-469
(2003).
3. Peyssonnaux, C., and Eychene, A., The
Raf/MEK/ERK pathway: new concepts of
activation. Biol. Cell, 93, 53-62 (2001).
4. Johnson, G.L., and Lapadat
Product Information - 60403
phenomenon of specific salt extraction. A. A. Shul´ga, B. Ahlers,
K. Cammann, J. Electroanal. Chem., 395, 305 (1995).
22 K. Seiler, Ion-selective Optode Membranes, monograph, describing theory, preparation and
Protein Phosphatases Technical Bulletin
Phosphatase 1B measured by the increase in tyrosine fluorescence which can be monitored at
Substrate II 305 nm following excitation at 280 nm.
Protein Tyrosine 539740 1441 Specific, sensitive fluorescence
MultiScreen Permeability Plates: The evaluation of the reproducibility of passive, transcellular drug permeability assays
a trademark of Biohit Oy.
Lit. No. AN1725EN00 Rev. A 12/02 Printed in the U.S.A. 02-305
© 2002 Millipore Corporation, Bedford, MA 01730 U.S.A. All
Strategies for Enhancing the Accumulation and Retention of Extracellular Matrix in Tissue-Engineered Cartilage Cultured in Bioreactors
Eng B 16: 305–329.
2. Vunjak-Novakovic G, Freed LE, Biron RJ, Langer R (1996) Effects of mixing on
the composition and morphology of tissue-engineered cartilage. AIChE J 42:
850–860.
3. Gooch
Application Notes United States Pharmacopeia Methods Purospher®STAR Columns for Regulated Drug Analysis
- 0.1
Total impurities - - 0.5
1 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol.
2 At 305 nm.
3 5-(Difluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1-methyl-1H-benzimidazole
Amidine-Based Catalysts (ABCs)- Design Development and Applications
equiv)
i-Pr2NEt (5.0 equiv)
CH2Cl2, 27 h
53%, 97% ee
MeO2C
MeO2C
H
Me
O
H
[cat]+
–O
H H
COCl
0 to 23 oC, 6–24 h
(1.3 equiv)3.
E
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
monocyte chemoattractant protein-1 in healthy and critically ill
dogs. Vet Clin Pathol 2010; 39: 302–305.
30. Olsson M, Frankowiack M, Tengvall K et al. The dog as a genetic
model for immunoglobulin A
United States Pharmacopeia Methods Purospher®STAR Columns for Regulated Drug Analysis
- 0.1
Total impurities - - 0.5
1 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol.
2 At 305 nm.
3 5-(Difluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1-methyl-1H-benzimidazole
Evaluation of Intracellular Signaling - Downstream Chimeric Antigen Receptors
central memory cells establishes persistent T cell memory in primates. J Clin
Invest. 2008; 118(1):294–305. Epub 2007/12/07. doi: 10.1172/JCI32103 PMID: 18060041; PubMed
Central PMCID: PMC2104476.
43. Hinrichs
Aldrichimica Acta Volume 50 Number 2
increased by 3 orders of
magnitude. The low pH required for efficient condensation was a final
constraint that was addressed through substitution of the aminooxy
group with hydrazine.53
Of note
Calbiochem Biologics 29.4
Immunogen used was a recombinant TRAF6 GST-fusion protein 100 µg
Mouse (Rabbit) containing amino acids 1-305. Detects the 58 kDa TRAF6. IB, IP
*Key: IB: Immunoblotting; IC: Immunocytochemistry: IP: Immunoprecipitation
Stem Cell and Specialty Cell Culture Product Guide
Intracellular 3 3 3 3 3 3
Dppa-1 Intracellular 3 ? ? ? ? ?
Dppa-3 Intracellular 3 ? ? ? ? ?
Dppa-5 Intracellular 3 ? ? ? ? ?
Nanog Intracellular 3 3 3
Calbiochem Biologics 31.2
domain with the active caspase.
Purity: ≥95% by SDS-PAGE. M.W. 72,300.
Cat. No. 539661 50 µg $ 305
Ref.: Herrera, B., et al. FEBS Lett. 520, 93; Deveraux, Q.L. and Reed, J.C. 1999. Genes
Dev.
Page 1 of 2